We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Search consultants continue to say that there is an unprecedented opportunity for visionary healthcare/life sciences leaders to redefine the future of the industry. A shifting economic climate and the rapid pace of innovation have fueled many changes in the healthcare industry through acquisitions, divestitures, and new company formations. The pandemic accelerated the adoption of technologies
Life sciences recruiting specialist Coulter Partners has recruited Jose Lora as chief scientific officer and Heather Hirsch as SVP of translational science and cancer biology of hC Bioscience. “It was our pleasure to work with Coulter Partners and we thank the team for their professionalism and outstanding support in making these appointments, both of which are critical to
Life sciences recruiting specialist Coulter Partners has formed a partnership with the Institute of Neurodiversity (ION). As a global neurodiversity changemaking organization and community, ION looks to foster awareness, acceptance, and appreciation of neurodiversity. They work with organizations, governments, the third sector, educators, and policymakers to raise awareness and advocate for policies that support neurominority inclusion. “We
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Michael Akoh as the new chief executive officer of ArcticZymes Technologies, a Norwegian life sciences company. Past CEO Jethro Holter stepped down for personal reasons. “We are very fortunate to have engaged Michael as our next CEO,” said Marie Roskrow, ArcticZymes’ chairman of the board. “Coulter Partners ran
Coulter Partners is proud of the successful placement of Valerio Ferri as Chief Executive Officer (CEO) at ExoLab Italia. ExoLab Italia is a biotech company producing plant-based exosomes for the cosmetics, nutraceutical, and pharmaceutical markets. With extensive experience in the nutraceutical and pharmaceutical sectors, Valerio Ferri joins ExoLab Italia after holding senior roles in leading companies such as Biofarma Group, where he
Coulter Partners successfully completed a search assignment for the Cell and Gene Therapy Catapult (CGT Catapult) and is pleased to announce the placement of Dr. Ed Samuel as Chief Operations Officer (COO). CGT Catapult is an independent technology and innovation organization specializing in the advancement of the cell and gene therapy industry through powerful collaborations. Ed Samuel has over 20 years of experience in
Coulter Partners successfully completed a search assignment for AstriVax Therapeutics NV and is pleased to announce the placement of Dieter Weinand as Chair of its Board of Directors. AstriVax Therapeutics is a clinical stage immunotherapy company developing novel treatments for chronic infections based on its proprietary plug and play plasmid-based Launch-iT technology. US-based Dieter Weinand is the former Chief Executive Officer of Bayer
Coulter Partners successfully completed a search assignment for QBiotics and is pleased to announce the placement of Sergio Duchini as Non-executive Director. QBiotics is an unlisted public Australian life sciences company that specializes in the discovery and development of novel small molecules to treat complex medical conditions. Its current therapeutic focus is on oncology and
Coulter Partners successfully completed a search assignment for iOnctura and is pleased to announce the placement of Steven Sciuto as Chief Financial Officer. iOnctura is a clinical-stage precision oncology company combating neglected and hard-to-treat cancers with a pipeline of first-in-class small molecules. Steven Sciuto is a seasoned finance executive with more than 15 years of
News
Top hires for Q3-2025
Top hires for Q2-2025
Coulter Partners: Fostering Digital Health connections on the Seine
Coulter Partners at BIA Women in Biotech: Driving diversity in Life Sciences leadership
Coulter Partners joins key discussion on HealthTech Boards at NHS Innovation Accelerator day
Coulter Partners at the BIA Life Science Leadership Summit: Fostering Board Excellence and UK Biotech Growth!
Coulter Partners attends LabCentral’s Luminescence: Rise & Fund event in Boston, MA
Leadership in MedTech: Key insights from our Paris roundtable
Coulter Partners co-hosts premier UK HealthTech Super Connector event
Coulter Partners attends Bio€quity Europe in Bruges, Belgium
Coulter Partners attends Danish Biotech Spring Gala
Top hires for VC & PE portfolio companies Q1-2025
Evolution Italy: Life Science leaders gather for insightful discussions
Coulter Partners at BioCapital Europe 2025: Innovation and optimism reign
BioInnovation Institute Breakfast Seminar Health Tech Ecosystem – Copenhagen
BIA Gala Dinner 2025
Top hires for VC & PE portfolio companies Q4-2024
Top global hires for large-cap, mid-cap and public companies H2-2024